Targeted Medical

PINK:TRGM USA Drug Manufacturers - Specialty & Generic
Market Cap
$3.02K
Market Cap Rank
#47976 Global
#14776 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.10
About

Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; slee… Read more

Targeted Medical (TRGM) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2015: -0.006x

Based on the latest financial reports, Targeted Medical (TRGM) has a cash flow conversion efficiency ratio of -0.006x as of December 2015.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($76.54K) by net assets ($-12.92 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Targeted Medical - Cash Flow Conversion Efficiency Trend (2008–2015)

This chart illustrates how Targeted Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Targeted Medical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Targeted Medical ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Targeted Medical (2008–2015)

The table below shows the annual cash flow conversion efficiency of Targeted Medical from 2008 to 2015.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2015-12-31 $-12.92 Million $-1.28 Million 0.099x +226.48%
2014-12-31 $-9.97 Million $780.31K -0.078x -126.83%
2013-12-31 $-7.02 Million $-2.05 Million 0.292x -75.40%
2012-12-31 $-2.00 Million $-2.37 Million 1.185x +127.85%
2011-12-31 $607.43K $-2.59 Million -4.257x -2229.13%
2010-12-31 $2.90 Million $579.40K 0.200x +145.87%
2009-12-31 $10.95 Million $890.54K 0.081x +1030.16%
2008-12-31 $6.94 Million $49.96K 0.007x --